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RESUMO: “Atividade antimicrobiana de espécies de Byrsonima (Malpighiaceae)”. Espécies 
de Byrsonima, família Malpighiaceae, são popularmente conhecidas como “murici”. Existem 
várias propriedades atribuídas às folhas de espécies de Byrsonima incluindo febrífuga, no 
tratamento de disfunções gastrintestinais e doenças de pele. Neste trabalho avaliamos a atividade 
antimicrobiana dos extratos das folhas de Byrsonima fagifolia, B. basiloba e B. intermedia usando 
o método de difusão em disco. Os resultados obtidos mostraram que os extratos metanólicos das 
folhas apresentaram atividade antimicrobiana contra todos os microrganismos testados.
Unitermos: Malpighiaceae, Byrsonima, atividade antimicrobiana.
ABSTRACT: Byrsonima species, family Malpighiaceae, is popularly known as “murici”. 
There are several properties attributed to the leaves of Byrsonima species including febrifuge, 
to treat gastrointestinal dysfunctions and skin diseases. In this work, the antimicrobial activity 
of Byrsonima fagifolia, B. basiloba and B. intermedia extracts obtained from the leaves were 
evaluated by using the disc-diffusion method. The results obtained showed that the methanol 
extracts of leaves had presented antimicrobial activity against all the microorganisms tested.
Keywords: Malpighiaceae, Byrsonima, antimicrobial activity.
INTRODUCTION
Medicinal plants are natural resources, leading 
to valuable herbal products, which are often used in the 
treatment of various diseases.
The Cerrado, a Brazilian savanna, comprises a 
very rich and characteristic fl ora. Many of these plants 
are used as natural medicines by the people living in 
this region to treat several tropical diseases including 
schistosomiasis, leishmaniasis, malaria, fungal and 
bacterial infections (Ferreira, 1980; Corrêa, 1984; 
Grandi et al., 1989; Di Stasi, 1989; Hirschmann & Arias, 
1990; Brandão, 1991; Caribé & Campos, 1991; Martins 
et al., 1994; Matos, 1994).
Fungi and bacteria cause important human 
diseases, especially in tropical regions and in 
immunocompromised or immunodefi cient patients. 
Despite the existence of potent antibiotic and antifungal 
agents, resistant or multi-resistant strains are incessantly 
appearing, imposing the need for search and development 
of new drugs (Silver & Bostian, 1993).
In an effort to discover new lead compounds, 
many research groups screen plant extracts to detect 
secondary metabolites with relevant biological activities 
based on  ethnopharmacological uses (Bezerra et al., 
2006; Funke & Melzig, 2006; Leitão et al., 2006; Lima et 
al., 2006; Barbosa-Filho et al., 2007; Saúde-Guimarães 
& Faria, 2007; Rodríguez et al., 2008). Byrsonima 
species are widely distributed throughout “Cerrado” and 
in the region Northeast of Brazil. Leaves are used against 
fever and ulcers, including dermal and gastrointestinal 
diseases (Silva et al., 2001; Lopez et al., 2001; Agra et 
al., 2007 and 2008). Chemical investigation of species 
belonging in to this genus resulted in the isolation of 
steroids, triterpenes, fl avonoids, proanthocyanidins and 
sulphonoglycolipids (Rastrelli et al., 1997; Mendes 
et al., 1999; Bejar et al., 1995). We have previously 
reported the isolation and/or identifi cation of quercetin 
derivatives, galloyl quinic acids, proanthocyanidins 
besides the dimeric fl avonoid amentofl avone and minor 
amounts of galloyl hexose and galloyl saccharose in 
the B. crassa leaves extract (Sannomiya et al., 2004; 
Sannomiya et al., 2005a; Sannomiya et al., 2005b; 
Sannomiya et al., 2005c). Some biological activities of 
Byrsonima species have been previously investigated. 
The methanol and hydromethanol extracts from B. 
basiloba (formerly documented as B. cinera) leaves 
have presented anti-diarrhea activity (Figueiredo et al., 
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2005). The polar extracts of B. crassa leaves showed 
a potential antiulcerogenic effect in mice (Sannomiya 
et al., 2005a). The methanol extract of B. crassifolia 
leaves showed strong giardicidal activity (Amaral et 
al., 2006). The ethyl acetate of B. crassifolia roots was 
active against Klebsiella pneumoniae, Pseudomonas 
aeruginosa, Salmonella typhi, Shigella fl exneri, 
Staphylococcus aureus, S. epidermidis, Streptococcus 
pneumoniae and Micrococcus luteus (Martinéz-Vasquez 
et al., 1999). The preliminary biological screening 
indicated that EMeOH and EMeOH 80%, including 
both the EtOAc and aqueous fractions of EMeOH, 
showed antimicrobial activity against Staphylococcus 
epidermidis, Bacillus cereus, B. subtilis, Salmonella 
sp., Proteus mirabilis, Enterococcus faecalis, Shigella 
sp. and Candida albicans (Sannomiya et al., 2005c). 
Despite the popular use of B. basiloba, B. intermedia 
and B. fagifolia as medicinal plants, there are no data 
about the antimicrobial effect of their leaf extracts. Thus, 
the interest in these plants is justifi able because of their 
potential medicinal value. The present study has the 
aim to evaluate the antimicrobial activity of Byrsonima 




Eight microbial species were analyzed, which 
were taken from international collections. The bacteria 
Bacillus subtilis (ATCC 9372), Bacillus cereus (ATCC 
14579), Shigella spp (IAL 1578), Staphylococcus 
epidermidis (ATCC 12226), Proteus mirabilis (CDC 
305), Salmonella spp (ATCC 19196), Enterococcus 
faecalis (ATCC 29212), and the yeast Candida albicans 
(ATCC 10231). 
Plant material
Leaves of Byrsonima fagifolia Niedenzu (IK) 
were collected by Dr. Clélia A. Hiruma-Lima at Porto 
Nacional, State of Tocantins, Brazil. The plant was 
identifi ed by Prof. Dr. Eduardo Ribeiro dos Santos, 
Department of Botany, Universidade do Tocantins - State 
of Tocantins, where a voucher specimen was deposited 
(nº 6398). The plant material of Byrsonima basiloba A. 
Juss. (nº 24163) and B. intermedia A. Juss. (nº 24164) 
were collected by Luiz Fernando Rolim de Almeida at 
Pratânia, State of São Paulo, Brazil and authenticated 
by Dr. Clemente José Campos and deposited at the 
Herbarium of Unesp - Botucatu.
Extract preparation
The air-dried and powdered leaves of all 
Byrsonima species were extracted separately and 
exhaustively with CHCl3, MeOH and 80% MeOH 
successively at room temperature (48 h for each solvent). 
Solvents were evaporated at 60 °C under reduced 
pressure affording the extracts coded as ECHCl3, 
EMeOH and EMeOH 80% (Table 1). 
Phytochemical screening
The chromatographic analyses were made by 
TLC on Si gel eluted with the mobile phases: CHCl3/
MeOH (70:30, v:v) and CHCl3/MeOH/H2O (80:18:2, 
v/v).
Chromatographic evaluation of the MeOH and 
80% MeOH extracts by TLC revealed with NP/PEG 
(diphenylaminoborate/polyethyleneglycol) reagent 
(Wagner et al., 1984) produced intense orange and 
yellow spots characteristic of fl avonoids and plates 
revealed with anisaldehyde/sulfuric acid solution 
also produced reddish and gray spots, suggesting 
the presence of catechin derivatives and phenolic 
compounds, respectively. We also spotted authentic 
standards (Sigma) of quercetin, myricetin, kaempferol, 
(+)-catechin, (-)-epicatechin, gallic acid and methyl 
gallate.
The detection of the tannins were realized 
according to the proceedings described by Simões et 
al. (2001) using the reaction the reaction with iron salts 
Schneider (1990) and with the gelatin.
Iodine vapors and saturated solution of H2SO4/
CeSO4 (saponins and terpenes) and anisaldehyde/ H2SO4 
solution (fl avonoids, terpenes, saponins, gallic acid 
derivatives and catechins) (Wagner et al., 1984) were 
also used.
The classes of compounds found in the EMeOH 
and MeOH 80% leaves extracts of Byrsonima species 
are indicated in Table 2.
Disc-diffusion method
The dried plant extracts of leaves and barks 
were dissolved in the same solvent (MeOH and CHCl3) 
to a fi nal concentration of 30 mg/mL. After, they were 
sterilized by fi ltration through 0.45 μm Millipore fi lters. 
Antimicrobial tests were carried out by disc-diffusion 
method (Bauer et al., 1966).
The microorganism cultures were grown in 
Brain Heart Infusion liquid medium at 37 ºC. After 6 h of 
growth, each microorganism culture, at a concentration 
of 106 cells/mL, was inoculated on the surface of Mueller-
Hinton agar plates (100 μL). Subsequently, fi lter papers 
discs (6 mm in diameter) saturated with extracts (20 
μL) were placed on the surface of each inoculated plate, 
in Brain Heart Infusion solid medium. The plates were 
incubated at 35 ºC for 24 h for bacteria and for 48 h 
for C. albicans. After this period, the zones of growth 
inhibition around the discs were measured. Overall, 
cultured microorganisms with inhibition zones equal to 
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or greater than 7 mm were considered susceptible to the 
tested extract (Nascimento et al., 2000).
The negative control was the solvent used and 
the positive control was ciprofl oxacin (5 μg/disc) for 
bacteria and ketoconazole (40 μg/disc) for C. albicans. 
All determinations were made in duplicate.
Minimum inhibitory concentration
The minimum inhibitory concentration (MIC) 
was determined by the dilution method according to 
National Committee for Clinical Laboratory Standards 
(NCCLS, 2003). The bacteria were grown in nutrient 
broth (Brain Heart Infusion liquid medium) for 6 h. 
After that 20 μL of 106 cells/mL were inoculated in 
tubes containing nutrient broth supplemented with eight 
different concentrations (0.75, 1.50, 3.0, 6.0, 12.0, 15.0, 
18.0 and 24.0 mg/mL) of the extracts. The tubes were 
incubated at 37 ºC for 24 h for bacteria and for 48 h, for 
C. albicans. The lowest concentrations, which did not 
show any growth of tested organism after macroscopic 
evaluation were determined as MIC. All determinations 
were made in duplicate (Nascimento et al., 2000).
RESULTS AND DISCUSSION
As shown in Table 1, the extracts of the leaves 
of Byrsonima basiloba, B. intermedia and B. fagifolia 
were prepared by maceration with chloroform, methanol 
and hydromethanol solvents. 
The results of the phytochemical screening of 
these species (Table 2) showed the presence of catechins, 
tannins, gallic acid derivatives and fl avonoids in the B. 
basiloba and B. intermedia species. Previously we have 
reported the isolation of (+)-catechin and quercetin-3-O-
α-L-arabinopyranoside from the EMeOH of the leaves 
of B. basiloba (Figueiredo et al., 2005). However, B. 
fagifolia presented only gallic acid derivatives and 
fl avonoids in its composition. This result confi rms those 
related before with the analytical approach based on the 
liquid chromatography/electrospray ionization tandem 
mass spectrometry from the infusion of the B. fagifolia. 
The analysis permitted the detection of fi ve fl avonoids 
glycosides and twenty galloyl quinic acid derivatives 
(Sannomiya et al., 2007).
In this work were evaluated the antimicrobial 
activity of all the extracts prepared from these Byrsonima 
species against seven bacteria and one yeast. The 
EMeOH and EMeOH 80% extracts were proved to be 
good solvents in extracting inhibitory compounds from 
tested plants. The other hand the ECHCl3 extracts of all 
species showed inactive against to the microorganisms 
evaluated.
In the assay against the microorganisms using 
the agar diffusion method (Table 3), the mean zones 
of inhibition obtained were between 7 to 14 mm. The 
MICs values observed was between 1.5 and 12.0 mg/
mL. In fact, lowers MIC values were associated with the 
EMeOH from B. intermedia against E. faecalis (1.5 mg/
mL) and B. subtilis (3.0 mg/mL). 
The EMeOH 80% extract of the leaves from 
B. fagifolia showed to be most active against B. cereus, 
E. faecalis and Shigella with MICs values of 3.0 mg/
mL than EMeOH with MICs values of 6.0, 7.5 and 6.0, 
respectively (Table 3). The presence of galloyl quinic 
acid derivatives on this extract can be responsible to the 
observed activity. This class of compounds has been 
recognized as possessing high activity against bronchial 
hyper-reactivity, allergic reactions, antiherpetic, 
anti-human immunodefi ciency virus (HIV) reverse 
transcriptase, and anti-HIV activity (Bokech et al., 
1996; Nishizawa et al., 1989).
Theses results can be explained based on the 
larger amount of the galloyl quinic acids derivatives 
Species  ECHCl3 (g) (yield %) EMeOH (g) (yield %) EMeOH 80% (g) (yield %) 
B. basiloba (1000 g) 77.7 (7.7%) 94.2 (9.4%) 63.1 (6.1%) 
B. intermedia (590 g) 16.7 (2.8%) 85.2 (14.4%) 29.6 (5.0%) 
B. fagifolia (1000 g) 47.3 (4.7%) 24.6 (2.5%) 12.9 (1.3%) 
Table 1. Extracts obtained from Byrsonima species.
Table 2. Phytochemical screening of Byrsonima species.
absent = (-); present = (+); ECHCl3 = chloroform extract; EMeOH = methanol extract; EMeOH 80% = hydromethanol extract; 
GAD = gallic acid derivatives.
Test B. fagifolia B. basiloba B. intermedia 
 ECHCl3 EMeOH EMeOH 
80% 
ECHCl3 EMeOH EMeOH 
80% 
ECHCl3 EMeOH EMeOH 
80% 
Catechins - - - - + + - + + 
Tannins - - - - + + - + + 
GAD - + + - + + - + + 
Flavonoids - + + - + + - + + 
Saponins - - - - - - - - - 
Terpenes + - - + - - + - - 
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on the EMeOH 80% than EMeOH. This difference 
can be expected by the higher polarity of the solvent 
extraction.
The results appear promising for a possible use 
of the B. intermedia and B. fagifolia or their components 
as antimicrobial agents. However, further studies are 
necessary to evaluate the toxic effects of these extracts.
Further phytochemical studies are in progress 
to establish which are the compounds responsible 
for the bioactivity of these medicinal plants and thus 
ascertain the value of the ethnobotanical approach for 
the screening of plants as potential sources of bioactive 
substances.
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